HER2 tumor marker tests are used to determine whether breast cancer is HER2 positive or negative. A person is a candidate for ...

REDWOOD CITY, Calif., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted ...

Danielle Fishel shared her breast cancer diagnosis this week, revealing on Monday’s episode of her podcast, “Pod Meets World,” that she is being treated for ductal carcinoma in situ.

Ductal carcinoma in situ (DCIS), also known as intraductal carcinoma, accounts for 1 of every 5 new breast cancer diagnoses. It's an uncontrolled growth of cells within the breast ducts.

Of the 22,753 women with unilateral ductal carcinoma in situ undergoing surgery, those who had mastectomy had a lower 25-year cumulative rate of ipsilateral invasive breast cancer (8.2%) compared ...

On July 20, 2023, a new editorial paper was published in Oncotarget, entitled, “Multiclonality of ER expression in DCIS – Implications for clinical practice and future research.” ...

Ductal carcinoma in situ: to treat or not to treat, that is the question M V Seijen and others British Journal of Cancer, August 2019. Volume 121, Issue 4, Pages 285 to 292 Breast cancer in situ E R ...

Background: Patients diagnosed with non-invasive breast lesions such as DCIS and lobular carcinoma in situ (LCIS) and atypical breast lesions such as atypical ductal hyperplasia (ADH) and atypical ...

A substantial portion of ductal carcinoma in situ recurrences did not appear genetically related to their primary lesions, according to study findings presented at American Association for Cancer ...

A qualitative exploration of survivor concerns surrounding the diagnosis and treatment of ductal carcinoma in situ, Cancer (2022). DOI: 10.1002/cncr.34126 ...

Each year in the United States, nearly 50,000 women are diagnosed with ductal carcinoma in situ (DCIS), a non-invasive breast condition that cannot spread. New research published by Wiley online ...

Ductal carcinoma in situ (DCIS), or stage 0 breast cancer, is considered a non-invasive or pre-invasive cancer. Treatment—such as surgery, radiation therapy, hormone-blocking medications, or ...